Literature DB >> 10962570

Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8.

H Kovar1, G Jug, D Printz, S Bartl, G Schmid, J Wesierska-Gadek.   

Abstract

To dissect the p53-dependent apoptotic pathway, events following induction of temperature sensitive (ts) p53val138 were studied in a Ewing tumor cell line. Transcriptional deregulation of p53 targets first observable after 1 h at 32 degrees C preceded activation of caspases and the break-down of mitochondrial respiratory activity. Activation of caspases was first observed 4 h after p53 induction. Using peptide inhibitors we identified activation of caspase 8 upstream of caspases-9 and -3. Although the caspase 8 specific inhibitor z-IETD.fmk did not affect translocation of BAX to the mitochondrial membrane and cytochrome C release it almost completely blocked cleavage of the prototype caspase substrate PARP and DNA fragmentation while enforcing mitochondrial depolarization and production of reactive oxygene species (ROS). Activation of caspase 8 did not involve death-domain receptor signaling. Expression of BCL2 only partially suppressed caspase activation but blocked apoptosis. Replacement of the N-terminus of p53val138 by the related VP16 transactivation domain created a ts p53 with a tanscriptional activity indistinguishable from p53val138 until the time of caspase activation. However, the VP16 - p53 fusion failed to trigger caspases and subsequent induction of the ROS producing gene pig3 paralleled by complete loss of apoptotic activity. These results indicate that p53-dependent transcriptional deregulation, triggering of the caspase cascade and the mitochondrial break-down occur in a timely ordered sequence coordinated by the genuine p53 amino terminus and suggest caspase 8 and PIG3 as key regulatory elements in this process. Oncogene (2000) 19, 4096 - 4107

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962570     DOI: 10.1038/sj.onc.1203780

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD.

Authors:  Christina Berube; Louis-Martin Boucher; Weili Ma; Andrew Wakeham; Leonardo Salmena; Razqallah Hakem; Wen-Chen Yeh; Tak W Mak; Samuel Benchimol
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-23       Impact factor: 11.205

2.  The antioxidant function of the p53 tumor suppressor.

Authors:  Anna A Sablina; Andrei V Budanov; Galina V Ilyinskaya; Larissa S Agapova; Julia E Kravchenko; Peter M Chumakov
Journal:  Nat Med       Date:  2005-11-13       Impact factor: 53.440

3.  A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene.

Authors:  S Bartl; J Ban; H Weninger; G Jug; H Kovar
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  Targeted therapy in Ewing sarcoma.

Authors:  A Lissat; M M Chao; U Kontny
Journal:  ISRN Oncol       Date:  2012-05-28

5.  Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine.

Authors:  Józefa Wesierska-Gadek; Tanja Schreiner; Margarita Maurer; Astrid Waringer; Carmen Ranftler
Journal:  Cell Mol Biol Lett       Date:  2007-01-19       Impact factor: 5.787

6.  PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.

Authors:  Józefa Węsierska-Gądek; Nora Zulehner; Franziska Ferk; Andrzej Składanowski; Oxana Komina; Margarita Maurer
Journal:  Biochem Pharmacol       Date:  2012-08-14       Impact factor: 5.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.